Juniper Pharmaceuticals Inc.

Aug 09, 2018

Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results

Jul 03, 2018

Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash

May 10, 2018

Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

Apr 25, 2018

Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience

Mar 21, 2018

Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors

Mar 08, 2018

Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results

Jan 31, 2018

Juniper Pharmaceuticals to Explore Strategic Alternatives

Jan 08, 2018

Juniper Pharmaceuticals Announces 4.5-Year Extension through 2024 of CRINONE® Supply Agreement with Merck KGaA, Darmstadt, Germany

Jan 02, 2018

Juniper Pharmaceuticals Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress

Dec 29, 2017

Juniper Pharma Services' co-founder awarded CBE in the Queen's New Year's Honours List

Sep 18, 2017

Juniper Pharmaceuticals Announces Strategic Reprioritization

Sep 11, 2017

Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors

Aug 03, 2017

Juniper Pharmaceuticals Reports Second Quarter 2017 Financial and Operating Results